The summary below is from the full report titled “Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction.” It is in the 1 February 2005 issue of Annals of Internal Medicine (volume 142, pages 157-164). The authors are S.E. Kimmel, J.A. Berlin, M. Reilly, J. Jaskowiak, L. Kishel, J. Chittams, and B.L. Strom.
Cyclooxygenase-2 Inhibitors and Heart Attacks: Varying Effects?. Ann Intern Med. 2005;142:I–21. doi: https://doi.org/10.7326/0003-4819-142-3-200502010-00001
Download citation file:
Published: Ann Intern Med. 2005;142(3):I-21.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use